Reporting and interpreting decision curve analysis: a guide for investigators
Context Urologists regularly develop clinical risk prediction models to support clinical
decisions. In contrast to traditional performance measures, decision curve analysis (DCA) …
decisions. In contrast to traditional performance measures, decision curve analysis (DCA) …
Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis
Objective To investigate the efficacy and safety of prostate-specific antigen (PSA) testing to
screen for prostate cancer. Design Systematic review and meta-analysis. Data sources …
screen for prostate cancer. Design Systematic review and meta-analysis. Data sources …
Screening for prostate cancer: US Preventive Services Task Force recommendation statement
DC Grossman, SJ Curry, DK Owens… - Jama, 2018 - jamanetwork.com
Importance In the United States, the lifetime risk of being diagnosed with prostate cancer is
approximately 11%, and the lifetime risk of dying of prostate cancer is 2.5%. The median age …
approximately 11%, and the lifetime risk of dying of prostate cancer is 2.5%. The median age …
Prostate-specific antigen–based screening for prostate cancer: evidence report and systematic review for the US Preventive Services Task Force
Importance Prostate cancer is the second leading cause of cancer death among US men.
Objective To systematically review evidence on prostate-specific antigen (PSA)–based …
Objective To systematically review evidence on prostate-specific antigen (PSA)–based …
Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trial
Importance Prostate cancer screening remains controversial because potential mortality or
quality-of-life benefits may be outweighed by harms from overdetection and overtreatment …
quality-of-life benefits may be outweighed by harms from overdetection and overtreatment …
Prostate cancer in primary care
Prostate cancer is a common malignancy seen worldwide. The incidence has risen in recent
decades, mainly fuelled by more widespread use of prostate-specific antigen (PSA) testing …
decades, mainly fuelled by more widespread use of prostate-specific antigen (PSA) testing …
Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer
T Nordström, O Akre, M Aly, H Grönberg… - Prostate cancer and …, 2018 - nature.com
Background Screening for prostate cancer using prostate-specific antigen (PSA) alone leads
to un-necessary biopsying and overdiagnosis. PSA density is easily accessible, but early …
to un-necessary biopsying and overdiagnosis. PSA density is easily accessible, but early …
Assessment of the diagnostic accuracy of biparametric magnetic resonance imaging for prostate cancer in biopsy-naive men: the biparametric MRI for detection of …
Importance Multiparametric magnetic resonance imaging (MRI) enhances detection and risk
stratification for significant prostate cancer but is time-consuming (approximately 40 minutes) …
stratification for significant prostate cancer but is time-consuming (approximately 40 minutes) …
Landmarks in prostate cancer
The field of prostate cancer has been the subject of extensive research that has resulted in
important discoveries and shaped our appreciation of this disease and its management …
important discoveries and shaped our appreciation of this disease and its management …
Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline
There is considerable variability among men's values and preferences regarding prostate
cancer screening. Men who place a high value in avoiding complications from biopsies and …
cancer screening. Men who place a high value in avoiding complications from biopsies and …